REFERENCES
- A. H. El-Kamel, M. S. Sokar, S. S. Al Gamel, and V. F. Naggar. 2001. Preparation and evaluation of ketoprofen floating oral delivery system. Int. J. Pharm. 220:13–21.
- M. Fujikawa, K. Takayama, and T. Nagai. 1998. Application of partitioned artificial neural networks to optimize pharmaceutical formulations. In Abstract of conference on challenges for drug delivery and pharmaceutical technology (p. 133). Tokyo, Japan.
- M. Ichikawa, S. Watanabe, and Y. Miyake. 1991. A new multiple-unit oral floating dosage system. I: Preparation and in vitro evaluation of floating and sustained-release characteristics. J. Pharm. Sci. 80:1062–1066.
- Y. Kawashima, T. Niwa, H. Takeuchi, T. Hino, and Y. Ito. 1991. Preparation of multiunit hollow microspheres (microballoons) with acrylic resins containing tranilast and their drug release characteristics (in vitro) and floating behavior (in vivo). J. Control. Release 16:279–290.
- P. L. Ritger, and N. A. Peppas. 1987. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J. Control. Release 5:37–42.
- K. Takayama, and T. Nagai. 1991. Simultaneous optimization for several characteristics concerning percutaneous absorption and skin damage of ketoprofen hydrogels containing d-limonene. Int. J. Pharm. 74:115–126.
- K. Takayama, M. Fujikawa, and T. Nagai. 1999. Artificial neural network as a novel method to optimize pharmaceutical formulations. Pharm. Res. 16:1–6.
- K. Takayama, A. Morva, M. Fujikawa, Y. Hattori, Y. Obata, and T. Nagai. 2000. Formula optimization of theophylline controlled-release tablet based on artificial neural networks. J. Control. Release 68:175–186.
- K. Takayama, M. Fujikawa, Y. Obata, and M. Morishita. 2003. Neural network based optimization of drug formulations. Adv. Drug Deliv. Rev. 55:1217–1231.
- B. C. Thanoo, M. C. Sunny, and A. Jayakrishnan. 1993. Oral sustained-release drug delivery systems using polycarbonate microspheres capable of floating on the gastric fluid. J. Pharm. Pharmacol. 45:21–24.
- Y. Miyazaki, Y. Onuki, S. Yakou, and K. Takayama. 2006. Effect of temperature-increase rate on drug release characteristics of dextran microspheres prepared by emulsion solvent evaporation process. Int. J. Pharm. 324:144–151.
- Y. Miyazaki, S. Yakou, and K. Takayama. 2007. Effect of amount of water in dispersed phase on drug release characteristics of dextran microspheres prepared by emulsion-solvent evaporation process. Biol. Pharm. Bull. 30:543–546.
- Y. Sato, Y. Kawashima, H. Takeuchi, and H. Yamamoto. 2004. In vitro and in vivo evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans. Int. J. Pharm. 275:97–107.
- B. Singh, and K. Kim. 2000. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J. Control. Release 63:235–259.
- S. Stithit, W. Chen, and J. C. Price. 1998. Development and characterization of buoyant theophylline microspheres with near zero order release kinetics. J. Microencapsul. 15:725–737.
- H. Yuasa, Y. Takashima, and Y. Kanaya. 1996. Studies on the development of intragastric floating and sustained release preparation. I. Application of calcium silicate as a floating carrier. Chem. Pharm. Bull. 44:1361–1366.
- P. C. Wu, Y. Obata, M. Fujikawa, C. J. Li, K. Higashiyama, and K. Takayama. 2001. Simultaneous optimization based on artificial neural networks in ketoprofen hydrogel formula containing O-ethyl-3-butylcyclohexanol as percutaneous absorption enhancer. J. Pharm. Sci. 90:1004–1014.